Edwards Lifesciences Reports Fourth Quarter Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall St tumbles on tech selloff as concerns about hawkish Fed, AI spending mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil drops $1 as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Edwards Lifesciences (EW) PT Raised to $174 at Canaccord Genuity
February 2, 2018 7:08 AM ESTCanaccord Genuity raised its price target on Edwards Lifesciences (NYSE: EW) to $174.00 (from $140.00) while maintaining a Buy rating. An analysis suggests the stock should trade to at least $174 by year-end, based solely on the fundamentals currently evident in the business, let alone... More
Edwards Lifesciences (EW) Tops Q4 EPS by 3c; Raises Outlook
February 1, 2018 4:17 PM ESTEdwards Lifesciences (NYSE: EW) reported Q4 EPS of $0.94, $0.03 better than the analyst estimate of $0.91. Revenue for the quarter came in at $888.5 million versus the consensus estimate of $867.09 million.
GUIDANCE:
Edwards Lifesciences sees Q1 2018 EPS of $1.04-$1.14. Edwards Lifesciences sees Q1 2018... More
